Tom Vanormelingen

Head of Market Access & Public Affairs Sandoz

Pharma Launch Excellence Summit Main Conference Day 1: Wednesday 2nd December

4:30 PM Case Study Presentation: Beyond Launch: Shaping Policy to Accelerate Biosimilar Uptake in Belgium

Biosimilars are entering the Golden Decade, yet uptake remains uneven across healthcare systems, limiting both patient access and healthcare sustainability.

Achieving launch excellence requires more than a successful product launch, it demands policy shaping, stakeholder alignment and a supportive adoption

environment. This session explores a multi-stakeholder initiative in Belgium aimed at identifying structural barriers, building stakeholder alignment and shaping policy recommendations to support sustainable biosimilar uptake from 33% to 66%. Through a real-world use case on designing and implementing a multi-stakeholder biosimilar policy initiative, attendees will learn how to identify structural barriers, engage key decision-makers and build the conditions for sustainable adoption. The session will also share early insights and lessons learned following the public launch of the initiative.

• Identifying the structural and policy barriers limiting biosimilar uptake

• Learning how to align policymakers, healthcare professionals and industry stakeholders around a shared vision

• Discovering practical steps to shape the policy environment needed for sustainable biosimilar adoption

• Exploring a real-world use case on building a national biosimilar policy roadmap to accelerate uptake and improve patient access

Check out the incredible speaker line-up to see who will be joining Tom.

Download The Latest Agenda

In Partnership With:

QUESTIONS?

Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: 44 (0) 207 368 9300
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk